📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MBX.
💹 Market Data
Market Cap$1.50B
Shares Outstanding47.60M
Float29.55M
Cash$439.98M
Debt$555.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.8% shares (2025Q4 vs prior)
141 institutional holders · 49.10M shares
#1
Frazier Life Sciences Management, L.P.
6.65M shares
#2
ORBIMED ADVISORS LLC
3.94M shares
#3
NEA Management Company, LLC
3.61M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest4.28M
Days to Cover5.0
% of Float14.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
3
FORM3
Mar 18, 2026
4
INSIDER TRANSACTION
Mar 16, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
8-K
8K EVENT
Feb 05, 2026
4
INSIDER TRANSACTION
Feb 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for MBX
📊 MBX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MBX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.